Under the multi-year partnership, MedStar will collect breast, lung and pancreatic biospecimens, among other cancer tissues, from select cancer programs at various hospitals in the MedStar Health Cancer Network. Researchers will be able to analyze these biospecimens to develop personalized cancer treatments for patients.
The partnership will also enable MedStar researchers to access existing biospecimens and clinical samples housed in Indivumed’s cancer database, which comprise data contributed by more than 30,000 patients in Europe, Asia and the United States.
More articles on health IT:
Report: 5 best, worst states for EHR adoption
Philips opens ‘innovation center’ in Pittsburgh
Meditech revenue dips 3% in Q2: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
